Capital Raising
Funding rounds, IPOs and capital events — capital raised becomes leadership hired.
Last updated
1,618
signals · last 90 days
1,435
trailing 4 weeks
18% ↑
share of signal mix
122.7
Talent Market Index · Hot →
On the wire — capital raising
Our intelligence detected 1,435 capital raising signals corpus-wide in the trailing four weeks. Below is the verified, sourced selection — every entry carries a checked source link and persists as its own page.
Boltz
EMEANvidia plans a minority investment in UK startup Boltz.
Leadership read: Fresh capital is a hiring signal before it is anything else. For Boltz, a raise in the sector funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where Boltz hires first across EMEA; that is where the capital is really pointed.
curated · 2026-10-16 · context →
Riverlane
EMEANvidia plans a minority investment in UK quantum-software company Riverlane.
Leadership read: Fresh capital is a hiring signal before it is anything else. For Riverlane, a raise in the sector funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where Riverlane hires first across EMEA; that is where the capital is really pointed.
curated · 2026-10-16 · context →
Scinai Immunotherapeutics Ltd.
EMEANasdaq-listed Scinai Immunotherapeutics closed a $4.0 million financing via private placement and warrant inducement, funding its CDMO operations and immunology therapeutic development.
Leadership read: Scinai Immunotherapeutics Ltd.'s raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across EMEA.
curated · 2026-10-16 · context →
Neonomics
EMEAOslo-based open finance company Neonomics secured $4 million from existing shareholders to fund its next growth phase after a restructuring that cut its operating cost base by nearly 50%.
Leadership read: Neonomics's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across EMEA.
curated · 2026-10-16 · context →
Jewish National Fund-USA
EMEAJewish National Fund-USA reported raising $192 million in fiscal 2026 (year ended Sept 30, 2026), taking its three-year total past $700 million, with a donor base of 664,033 and a goal of engaging one million supporters over the next decade.
Leadership read: Fresh capital is a hiring signal before it is anything else. For Jewish National Fund-USA, a raise in the sector funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where Jewish National Fund-USA hires first across EMEA; that is where the capital is really pointed.
curated · 2026-10-16 · context →
Solvera
EMEAOslo-based AI-native engineering services firm Solvera raised a $6.3M pre-seed round led by Seedcamp, with participation from Inception Fund, Momentum, PSV, Sondo, OBOS Ventures, Construct Venture and The Nordic Web Ventures, plus angels including Spacemaker founders.
Leadership read: Fresh capital is a hiring signal before it is anything else. For Solvera, a raise in the sector funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where Solvera hires first across EMEA; that is where the capital is really pointed.
curated · 2026-10-16 · context →
Salience Labs
EMEASalience Labs secured $125M to scale photonic chips for AI data centres.
Leadership read: Salience Labs's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across EMEA.
curated · 2026-10-16 · context →
EZO
EMEAEZO raised €150M in debt financing.
Leadership read: Fresh capital is a hiring signal before it is anything else. For EZO, a raise in the sector funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where EZO hires first across EMEA; that is where the capital is really pointed.
curated · 2026-10-16 · context →
Strive
AmericasStrive priced an upsized $630M IPO of SATS preferred stock.
Leadership read: Strive's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across Americas.
curated · 2026-10-16 · context →
Swamp Club
AmericasSan Francisco-based AI agent platform Swamp Club raised a $7M seed round led by Amplify Partners, with Encoded Ventures and angels participating. Funds will scale its behavior-centric AI agent platform for enterprise production use.
Leadership read: Fresh capital is a hiring signal before it is anything else. For Swamp Club, a raise in the sector funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where Swamp Club hires first across Americas; that is where the capital is really pointed.
curated · 2026-10-16 · context →
EMode Photonix
AmericasBoulder, Colorado photonics simulation software startup EMode Photonix raised a $1M pre-seed round led by Ground State Ventures, with Harlow Capital Management participating.
Leadership read: Fresh capital is a hiring signal before it is anything else. For EMode Photonix, a raise in the sector funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where EMode Photonix hires first across Americas; that is where the capital is really pointed.
curated · 2026-10-16 · context →
Frazier Life Sciences Acquisition Corp
AmericasFrazier Life Sciences is taking a biotech-focused SPAC public on Nasdaq, a blank-check vehicle raising capital to acquire a life sciences company.
Leadership read: Fresh capital is a hiring signal before it is anything else. For Frazier Life Sciences Acquisition Corp, a raise in the sector funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where Frazier Life Sciences Acquisition Corp hires first across Americas; that is where the capital is really pointed.
curated · 2026-10-16 · context →
- Boltz · 2026-10-16
- Riverlane · 2026-10-16
- Scinai Immunotherapeutics Ltd. · 2026-10-16
- Neonomics · 2026-10-16
- Jewish National Fund-USA · 2026-10-16
- Solvera · 2026-10-16
- Salience Labs · 2026-10-16
- EZO · 2026-10-16
- Strive · 2026-10-16
- Swamp Club · 2026-10-16
- EMode Photonix · 2026-10-16
- Frazier Life Sciences Acquisition Corp · 2026-10-16
- Confido Health · 2026-10-16
- Sprout Family · 2026-10-16
- IPX Exchange · 2026-10-16
- Chariot · 2026-10-16
- East Side Games Group · 2026-10-16
- Sharp Performance · 2026-10-16
- Aerium · 2026-10-16
- Sunbound · 2026-10-16
- Mueon Corp. · 2026-10-16
- Aldaron · 2026-10-16
- Curis, Inc. · 2026-10-16
- Alector · 2026-10-16
How this connects
Related companies
Recent developments
- Zoono Group — Capital Raising · Oceania · 2026-10-19
- 주빅 (JUVIC) — Capital Raising · Asia · 2026-10-19
- Blue Whale — Capital Raising · Asia · 2026-10-19
- The Pant Project — Capital Raising · Asia · 2026-10-19
- Hunger Pangs Pvt Ltd — Capital Raising · Asia · 2026-10-19
- Salmon Group — Capital Raising · Asia · 2026-10-19
Proof — case studies
- Executive search for HR-tech · Culture Amp
In their words
“the financial complexities of building and operating new clouds and selling to customers.”
“x402 answers how an agent pays, x401 answers who it is. Those are the first two questions any agentic transaction has to clear, and now each has an open standard.”
“a merger would create a leader in microbiome and infectious disease diagnostics, with broader revenue and customer bases and a materially stronger balance sheet to meet the significant global opportunity facing the merged group.”
- Data period
- 20 Mar 2026 – 19 Oct 2026 · 2,698 signals in this type
- Methodology
- How this is computed
- Publisher
- MitchelLake
Last updated
